Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 22, 2014 02:00 ET | Source: mdxhealth

ConfirmMDx Studies Highlighted by Elsevier, Publisher of The Journal of Urology®

Underscores Importance of Recent Confirmatory Clinical Validation Results Leading to Medicare Reimbursement Milestone IRVINE, CA, and HERSTAL, BELGIUM - July 22, 2014 -...
July 02, 2014 02:00 ET | Source: mdxhealth

MDxHealth and Miraca Life Sciences Announce Agreement to Promote ConfirmMDx for Prostate Cancer

IRVINE, CA, and HERSTAL, BELGIUM - July 2, 2014 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the...
June 23, 2014 04:36 ET | Source: mdxhealth

MDxHealth : Assemblée Générale Extraordinaire des actionnaires

IRVINE, CA, et HERSTAL, BELGIQUE, le 23 juin 2014 -MDxHealth SA (NYSE Euronext: MDXH), un leader du diagnostic moléculaire qui développe et commercialise des tests épigénétiques pour soutenir le...
June 23, 2014 04:36 ET | Source: mdxhealth

MDxHealth : Extraordinary General Shareholders' Meeting

IRVINE, CA, and HERSTAL, BELGIUM, 23 June 2014 -MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer...
June 20, 2014 02:00 ET | Source: mdxhealth

ConfirmMDx Draft Medicare Coverage Policy Posted for Public Comment

IRVINE, California, and HERSTAL, BELGIUM - June 20, 2014 - MDxHealth SA (NYSE Euronext: MDXH), today announced that a draft coverage policy (Local Coverage Determination or LCD) for the ConfirmMDx®...
June 17, 2014 02:00 ET | Source: mdxhealth

MDxHealth : déclaration de transparence d'un actionnaire

IRVINE, CA, et HERSTAL, BELGIQUE, le 17 juin 2014 -MDxHealth SA (NYSE Euronext: MDXH), un leader du diagnostic moléculaire qui développe et commercialise des tests épigénétiques pour soutenir le...
June 17, 2014 02:00 ET | Source: mdxhealth

MDxHealth Shareholder Transparency Notification

IRVINE, CA, and HERSTAL, BELGIUM, June 17th, 2014 -MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer...
May 30, 2014 05:25 ET | Source: mdxhealth

Assemblée Générale Ordinaire et Extraordinaire des actionnaires de MDxHealth

IRVINE, CA, et HERSTAL, BELGIQUE, le 30 mai 2014 -MDxHealth SA (NYSE Euronext: MDXH), un leader du diagnostic moléculaire qui développe et commercialise des tests épigénétiques pour soutenir le...
May 30, 2014 05:25 ET | Source: mdxhealth

MDxHealth's Annual and Extraordinary General Shareholders' Meeting

IRVINE, CA, and HERSTAL, BELGIUM, 30 May, 2014 -MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer...
May 20, 2014 02:00 ET | Source: mdxhealth

MDxHealth Reports 10-Fold Reduction of Repeat Prostate Biopsies in ConfirmMDx Clinical Utility Study

Results Published in American Health and Drug Benefits IRVINE, CA, and HERSTAL, BELGIUM - May 20, 2014 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and...